Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.

Tae Hata,Chikara Sakaguchi,Keita Hirano,Hiroshi Kobe,Masaki Ishida,Takayuki Nakano,Yusuke Tachibana,Nobuyo Tamiya,Shinsuke Shiotsu,Takayuki Takeda,Tadaaki Yamada,Toshihide Yokoyama,Michiko Tsuchiya,Yukio Nagasaka

Thoracic cancer（2023）

Cited 0|Views5

No score

Abstract

The effect of ABCP therapy and chemotherapy was comparable in EGFR-mutant patients in a real-world setting. The indication for immunochemotherapy should be carefully considered, especially in PD-L1-negative patients.

Translated text

Key words

EGFR mutation,advanced non-small cell lung cancer,immunochemotherapy,immunotherapy,platinum-based chemotherapy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined